Serologic testing of US blood donations to identify severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-reactive antibodies: December 2019–January 2020

Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China

Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang, L., Fan, G., Xu, J., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30183-5 · Cited by 48,884 · see citing works

A new coronavirus associated with human respiratory disease in China

Wu, F., Zhao, S., Yu, B., Chen, Y.-M., Wang, W., Song, Z.-G., Hu, Y., Tao, Z.-W., Tian, J.-H., Pei, Y.-Y., et al. (2020) · Nature · doi:10.1038/s41586-020-2008-3 · Cited by 11,688 · see citing works

Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation

Wrapp, D., Wang, N., Corbett, K. S., Goldsmith, J. A., Hsieh, C.-L., Abiona, O., Graham, B. S., & McLellan, J. S. (2020) · Science · doi:10.1126/science.abb2507 · Cited by 8,897 · see citing works

First case of 2019 novel coronavirus in the United States

Holshue, M. L., DeBolt, C., Lindquist, S., Lofy, K. H., Wiesman, J., Bruce, H., Spitters, C., Ericson, K., Wilkerson, S., Tural, A., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2001191 · Cited by 6,030 · see citing works

The proximal origin of SARS-CoV-2

Andersen, K. G., Rambaut, A., Lipkin, W. I., Holmes, E. C., & Garry, R. F. (2020) · Nature Medicine · doi:10.1038/s41591-020-0820-9 · Cited by 5,081 · see citing works

Estimating the asymptomatic proportion of coronavirus disease 2019 (COVID-19) cases on board the Diamond Princess cruise ship, Yokohama, Japan, 2020

Mizumoto, K., Kagaya, K., Zarebski, A., & Chowell, G. (2020) · Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · doi:10.2807/1560-7917.es.2020.25.10.2000180 · Cited by 2,336 · see citing works

Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibody

Pinto, D., Park, Y.-J., Beltramello, M., Walls, A. C., Tortorici, M. A., Bianchi, S., Jaconi, S., Culap, K., Zatta, F., De Marco, A., et al. (2020) · Nature · doi:10.1038/s41586-020-2349-y · Cited by 1,885 · see citing works

Severe Acute Respiratory Syndrome Coronavirus 2−Specific Antibody Responses in Coronavirus Disease Patients

Okba, N. M. A., Müller, M. A., Li, W., Wang, C., GeurtsvanKessel, C. H., Corman, V. M., Lamers, M. M., Sikkema, R. S., de Bruin, E., Chandler, F. D., et al. (2020) · Emerging Infectious Diseases · doi:10.3201/eid2607.200841 · Cited by 1,614 · see citing works

Preexisting and de novo humoral immunity to SARS-CoV-2 in humans

Ng, K. W., Faulkner, N., Cornish, G. H., Rosa, A., Harvey, R., Hussain, S., Ulferts, R., Earl, C., Wrobel, A. G., Benton, D. J., et al. (2020) · Science · doi:10.1126/science.abe1107 · Cited by 886 · see citing works

Emergence of genomic diversity and recurrent mutations in SARS-CoV-2

van Dorp, L., Acman, M., Richard, D., Shaw, L. P., Ford, C. E., Ormond, L., Owen, C. J., Pang, J., Tan, C. C. S., Boshier, F. A. T., et al. (2020) · Infection Genetics and Evolution · doi:10.1016/j.meegid.2020.104351 · Cited by 775 · see citing works

Neutralizing antibodies correlate with protection from SARS-CoV-2 in humans during a fishery vessel outbreak with a high attack rate

Addetia, A., Crawford, K. H. D., Dingens, A., Zhu, H., Roychoudhury, P., Huang, M.-L., Jerome, K. R., Bloom, J. D., & Greninger, A. L. (2020) · Journal of Clinical Microbiology · doi:10.1128/jcm.02107-20 · Cited by 525 · see citing works

Severe Acute Respiratory Syndrome Coronavirus 2 from Patient with Coronavirus Disease, United States

Harcourt, J. L., Tamin, A., Lu, X., Kamili, S., Sakthivel, S. K., Murray, J., Queen, K. J., Tao, Y., Paden, C. R., Zhang, J., et al. (2020) · Emerging infectious diseases · doi:10.3201/eid2606.200516 · Cited by 524 · see citing works

Special report: The simulations driving the world’s response to COVID-19

Adam, D. (2020) · Nature · doi:10.1038/d41586-020-01003-6 · Cited by 447 · see citing works

Evolutionary history, potential intermediate animal host, and cross‐species analyses of SARS‐CoV‐2

Li, X., Zai, J., Zhao, Q., Nie, Q. H., Li, Y., Foley, B. T., & Chaillon, A. (2020) · Journal of Medical Virology · doi:10.1002/jmv.25731 · Cited by 428 · see citing works

Clinical and virologic characteristics of the first 12 patients with coronavirus disease 2019 (COVID-19) in the United States

The COVID-19 Investigation Team (2020) · Nature Medicine · doi:10.1038/s41591-020-0877-5 · Cited by 401 · see citing works

SARS-CoV-2 was already spreading in France in late December 2019

Deslandes, A., Berti, V., Tandjaoui-Lambiotte, Y., Alloui, C., Carbonnelle, É., Zahar, J., Brichler, S., & Cohen, Y. (2020) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2020.106006 · Cited by 243 · see citing works

1970s and ‘Patient 0’ HIV-1 genomes illuminate early HIV/AIDS history in North America

Worobey, M., Watts, T. D., McKay, R. A., Suchard, M. A., Granade, T. C., Teuwen, D. E., Koblin, B. A., Heneine, W., Lemey, P., & Jaffe, H. W. (2016) · Nature · doi:10.1038/nature19827 · Cited by 221 · see citing works

Evidence for Limited Early Spread of COVID-19 Within the United States, January–February 2020

CDC COVID-19 Response Team, Jorden, M. A., Rudman, S. L., Villarino, E., Hoferka, S., Patel, M. T., Bemis, K., Simmons, C. R., Jespersen, M., Johnson, J. I., et al. (2020) · MMWR Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6922e1 · Cited by 168 · see citing works

Validation of a SARS-CoV-2 spike protein ELISA for use in contact investigations and sero-surveillancePreprint

Freeman, B. D., Lester, S. N., Mills, L. A., Rasheed, M. A. U., Moye, S., Abiona, O. M., Hutchinson, G. B., Morales-Betoulle, M. E., Krapinunaya, I., Gibbons, A., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.04.24.057323 · Cited by 92 · see citing works

Serology Enhances Molecular Diagnosis of Respiratory Virus Infections Other than Influenza in Children and Adults Hospitalized with Community-Acquired Pneumonia

Zhang, Y., Sakthivel, S. K., Bramley, A. M., Jain, S., Haynes, A., Chappell, J. D., Hymas, W. C., Lenny, N. T., Patel, A. R., Qi, C., et al. (2016) · Journal of Clinical Microbiology · doi:10.1128/jcm.01701-16 · Cited by 56 · see citing works

Implications of the impact of prevalence on test thresholds and outcomes: lessons from tuberculosis

Bentley, T. G. K., Catanzaro, A., & Ganiats, T. G. (2012) · BMC Research Notes · doi:10.1186/1756-0500-5-563 · Cited by 49 · see citing works

Use of Blood Donor Screening Data to Estimate Zika Virus Incidence, Puerto Rico, April–August 2016

Chevalier, M. S., Biggerstaff, B. J., Basavaraju, S. V., Ocfemia, M. C. B., Alsina, J. O., Climent, C., Moseley, R. R., Chung, K., Rivera-García, B., Bello-Pagán, M., et al. (2017) · Emerging infectious diseases · doi:10.3201/eid2305.161873 · Cited by 32 · see citing works

The Lancet Commission on lessons for the future from the COVID-19 pandemic

Sachs, J. D., Karim, S. S. A., Aknin, L., Allen, J., Brosbøl, K., Colombo, F., Barron, G. C., Espinosa, M. F., Gaspar, V., Gaviria, A., et al. (2022) · The Lancet · doi:10.1016/s0140-6736(22)01585-9 · Cited by 842 · see citing works

Lessons learned 1 year after SARS-CoV-2 emergence leading to COVID-19 pandemic

To, K. K., Sridhar, S., Chiu, K. H., Hung, D. L. L., Li, X., Hung, I. F., Tam, A. R., Chung, T. W., Chan, J. F., Zhang, J., et al. (2021) · Emerging Microbes & Infections · doi:10.1080/22221751.2021.1898291 · Cited by 350 · see citing works

How an outbreak became a pandemic: a chronological analysis of crucial junctures and international obligations in the early months of the COVID-19 pandemic

Singh, S., McNab, C., Olson, R. M., Bristol, N., Nolan, C., Bergstrøm, E., Bartos, M., Mabuchi, S., Panjabi, R., Karan, A., et al. (2021) · The Lancet · doi:10.1016/s0140-6736(21)01897-3 · Cited by 141 · see citing works

Cryptic transmission of SARS-CoV-2 and the first COVID-19 wave

Davis, J. T., Chinazzi, M., Perra, N., Mu, K., y Piontti, A. P., Ajelli, M., Dean, N. E., Gioannini, C., Litvinova, M., Merler, S., et al. (2021) · Nature · doi:10.1038/s41586-021-04130-w · Cited by 126 · see citing works

Immunogenicity and crossreactivity of antibodies to the nucleocapsid protein of SARS-CoV-2: utility and limitations in seroprevalence and immunity studies

Dobaño, C., Santano, R., Jiménez, A., Vidal, M., Chi, J., Melero, N. R., Popovic, M., López-Aladid, R., Fernández‐Barat, L., Tortajada, M., et al. (2021) · Translational research · doi:10.1016/j.trsl.2021.02.006 · Cited by 105 · see citing works

Evaluation and Comparison of Serological Methods for COVID-19 Diagnosis

Gong, F., Wei, H.-X., Li, Q., Liu, L., & Li, B. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.682405 · Cited by 103 · see citing works

SARS-CoV-2 genomics: An Indian perspective on sequencing viral variants

Srivastava, S., Banu, S., Singh, P., Sowpati, D. T., & Mishra, R. K. (2021) · Journal of Biosciences · doi:10.1007/s12038-021-00145-7 · Cited by 96 · see citing works

COVID-19: Understanding Inter-Individual Variability and Implications for Precision Medicine

Pereira, N. L., Ahmad, F., Byku, M., Cummins, N. W., Morris, A. A., OWENS, A. T., Tuteja, S., & Cresci, S. (2020) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2020.11.024 · Cited by 90 · see citing works

Emerging viruses: Cross-species transmission of coronaviruses, filoviruses, henipaviruses, and rotaviruses from bats

Tian, J., Sun, J., Li, D., Wang, N., Wang, L., Zhang, C., Meng, X., Ji, X., Suchard, M. A., Zhang, X., et al. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.110969 · Cited by 90 · see citing works

The origins of COVID‐19 pandemic: A brief overview

Hao, Y., Wang, Y., Wang, M.-Y., Zhou, L., Shi, J., Cao, J., & Wang, D. (2022) · Transboundary and Emerging Diseases · doi:10.1111/tbed.14732 · Cited by 103 · see citing works

The heterogeneity of the COVID-19 pandemic and national responses: an explanatory mixed-methods study

Chen, Y., & Assefa, Y. A. (2021) · BMC Public Health · doi:10.1186/s12889-021-10885-8 · Cited by 70 · see citing works

Social capital's impact on COVID-19 outcomes at local levels

Fraser, T., Page-Tan, C. M., & Aldrich, D. P. (2022) · Scientific Reports · doi:10.1038/s41598-022-10275-z · Cited by 49 · see citing works

The twin-beginnings of COVID-19 in Asia and Europe—one prevails quickly

Ruan, Y., Wen, H., Hou, M., He, Z., Lu, X., Xue, Y., He, X., Zhang, Y., & Wu, C. (2021) · National Science Review · doi:10.1093/nsr/nwab223 · Cited by 46 · see citing works

Prevalence and factors associated with SARS-CoV-2 seropositivity in the Spanish HIV Research Network Cohort

Berenguer, J., Díez, C., Martin‐Vicente, M., Micán, R., Pérez-Elı́as, M. J., García-Fraile, L. J., Vidal, F., Suárez‐García, I., Podzamczer, D., Romero, J. D., et al. (2021) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2021.06.023 · Cited by 48 · see citing works

SARS-CoV-2 IgG Antibodies Seroprevalence and Sera Neutralizing Activity in MEXICO: A National Cross-Sectional Study during 2020

Muñoz‐Medina, J. E., Grajales-Muñíz, C., Salas-Lais, Á. G., Fernandes-Matano, L., López-Macías, C. I. R., Monroy-Muñoz, I. E., Coy-Arechavaleta, A. S., Palomec-Nava, I. D., Duque-Molina, C., Madera-Sandoval, R. L., et al. (2021) · Microorganisms · doi:10.3390/microorganisms9040850 · Cited by 32 · see citing works

Antibodies to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in All of Us Research Program Participants, 2 January to 18 March 2020

Althoff, K. N., Schlueter, D. J., Anton‐Culver, H., Cherry, J. D., Denny, J. C., Thomsen, I. P., Karlson, E. W., Havers, F. P., Cicek, M. S., Thibodeau, S. N., et al. (2021) · Clinical Infectious Diseases · doi:10.1093/cid/ciab519 · Cited by 29 · see citing works

Severe Acute Respiratory Syndrome Coronavirus 2 Seroprevalence and Reported Coronavirus Disease 2019 Cases in US Children, August 2020–May 2021

Couture, A., Lyons, B. C., Mehrotra, M., Sosa, L. E., Ezike, N. O., Ahmed, F. S., Brown, C., Yendell, S. J., Azzam, I. A., Katić, B., et al. (2022) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofac044 · Cited by 26 · see citing works

Low seroprevalence of COVID-19 in Lao PDR, late 2020

Virachith, S., Pommelet, V., Calvez, E., Khounvisith, V., Sayasone, S., Kounnavong, S., Mayxay, M., Xangsayarath, P., Temmam, S., Éloit, M., et al. (2021) · The Lancet Regional Health - Western Pacific · doi:10.1016/j.lanwpc.2021.100197 · Cited by 21 · see citing works

Molecular evidence for SARS-CoV-2 in samples collected from patients with morbilliform eruptions since late 2019 in Lombardy, northern Italy

Amendola, A., Canuti, M., Bianchi, S., Kumar, S., Fappani, C., Gori, M., Colzani, D., Pond, S. L. K., Miura, S., Baggieri, M., et al. (2022) · Environmental Research · doi:10.1016/j.envres.2022.113979 · Cited by 25 · see citing works

SARS-CoV-2's origin should be investigated worldwide for pandemic prevention

Wu, Z., Jin, Q., Wu, G., Lu, J., Li, M., Guo, D., Lan, K., Feng, L., Qian, Z., Ren, L., et al. (2021) · The Lancet · doi:10.1016/s0140-6736(21)02020-1 · Cited by 23 · see citing works

Molecular evidence of SARS-CoV-2 in New York before the first pandemic wave

Hernandez, M. M., Gonzalez-Reiche, A. S., Alshammary, H., Fabre, S., Khan, Z., van de Guchte, A., Obla, A., Ellis, E., Sullivan, M. J., Tan, J., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-23688-7 · Cited by 19 · see citing works

An Overview of Current Knowledge of Deadly CoVs and Their Interface with Innate Immunity

Zhang, Y., Gargan, S., Lu, Y., & Stevenson, N. J. (2021) · Viruses · doi:10.3390/v13040560 · Cited by 18 · see citing works

Trends of new-onset psychosis or mania in psychiatric emergency departments during the COVID19 pandemic: a longitudinal comparative study

Segev, A., Klein, E. H., Kotz, G., Kamhi-Nesher, S., Halimi, S., Qashu, K., Schreiber, E., & Krivoy, A. (2021) · Scientific Reports · doi:10.1038/s41598-021-00310-w · Cited by 17 · see citing works

The East–West divide in response to COVID-19

Jamison, D. T., & Wu, K. B. (2021) · Engineering · doi:10.1016/j.eng.2021.05.008 · Cited by 16 · see citing works

Waiting for the truth: is reluctance in accepting an early origin hypothesis for SARS-CoV-2 delaying our understanding of viral emergence?

Canuti, M., Bianchi, S., Kolbl, O., Pond, S. L. K., Kumar, S., Gori, M., Fappani, C., Colzani, D., Borghi, E., Zuccotti, G., et al. (2022) · BMJ Global Health · doi:10.1136/bmjgh-2021-008386 · Cited by 15 · see citing works

Phylogenetic reconstruction of the initial stages of the spread of the SARS-CoV-2 virus in the Eurasian and American continents by analyzing genomic data

Bukin, Y. S., Bondaryuk, A. N., Kulakova, N. V., Балахонов, С. В., Dzhioev, Y. P., & Zlobin, V. I. (2021) · Virus Research · doi:10.1016/j.virusres.2021.198551 · Cited by 15 · see citing works

Timeline of SARS-CoV-2 Spread in Italy: Results from an Independent Serological Retesting

Montomoli, E., Apolone, G., Manenti, A., Boeri, M., Suatoni, P., Sabia, F., Marchianò, A. V., Bollati, V., Pastorino, U., & Sozzi, G. (2021) · Viruses · doi:10.3390/v14010061 · Cited by 13 · see citing works

Performance of SARS-CoV-2 Antigens in a Multiplex Bead Assay for Integrated Serological Surveillance of Neglected Tropical and Other Diseases

Gwyn, S. E., Abubakar, A. G., Akinmulero, O. O., Bergeron, É., Ugboaja, N. B., Chaitram, J. M., Coughlin, M. M., Dawurung, A. B., Nwatu, F., Esiekpe, M. K., et al. (2022) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.22-0078 · Cited by 13 · see citing works

Universal SARS-CoV-2 polymerase chain reaction screening and assisted reproductive technology in a coronavirus disease 2019 pandemic epicenter: screening and cycle outcomes from a New York City fertility center

Shaw, J., Tozour, J. N., Blakemore, J. K., & GRIFO, J. A. (2021) · Fertility and Sterility · doi:10.1016/j.fertnstert.2021.05.109 · Cited by 12 · see citing works

COVID ‐19 and future pandemics: is isolation and social distancing the new norm?

Collignon, P. (2021) · Internal Medicine Journal · doi:10.1111/imj.15287 · Cited by 14 · see citing works

Forensic analysis of the 38 subject deaths in the 6-Month Interim Report of the Pfizer/BioNTech BNT162b2 mRNA Vaccine Clinical Trial

Michels, C. A., Perrier, D., Kunadhasan, J., Clark, E., Gehrett, J., Gehrett, B., Kwiatek, K., Adams, S., Chandler, R. W., Stagno, L., et al. (2023) · International Journal of Vaccine Theory Practice and Research · doi:10.56098/ijvtpr.v3i1.85 · Cited by 11 · see citing works

Analysis of the Genomic Distance Between Bat Coronavirus RaTG13 and SARS-CoV-2 Reveals Multiple Origins of COVID-19

Pei, S., & Yau, S. S. ‐. (2021) · Acta Mathematica Scientia · doi:10.1007/s10473-021-0323-x · Cited by 10 · see citing works

Characterization of SARS-CoV-2 worldwide transmission based on evolutionary dynamics and specific viral mutations in the spike protein

Liu, J., Chen, X., Liu, Y., Lin, J., Shen, J., Zhang, H., Yin, J., Pu, R., Ding, Y., & Cao, G. (2021) · Infectious Diseases of Poverty · doi:10.1186/s40249-021-00895-4 · Cited by 10 · see citing works

Design of a population-based longitudinal cohort study of SARS-CoV-2 incidence and prevalence among adults in the San Francisco Bay Area

Lindan, C., Desai, M., Boothroyd, D. B., Judson, T. J., Bollyky, J., Sample, H. A., Weng, Y., Cheng, Y., Dahlen, A., Hedlin, H., et al. (2021) · Annals of Epidemiology · doi:10.1016/j.annepidem.2021.11.001 · Cited by 10 · see citing works

Globalization, population flow and the spatial diffusion of COVID-19

Shen, J. (2021) · Asian Geographer · doi:10.1080/10225706.2021.1910526 · Cited by 10 · see citing works

Strengthening serological studies: the need for greater geographical diversity, biobanking, and data-accessibility

Menezes, A., Razafimahatratra, S. L., Wariri, O., Graham, A. L., & Metcalf, C. J. E. (2025) · Trends in Microbiology · doi:10.1016/j.tim.2024.12.006 · Cited by 9 · see citing works

Characteristics of US Blood Donors Testing Reactive for Antibodies to SARS-CoV-2 Prior to the Availability of Authorized Vaccines

Dodd, R. Y., Spencer, B. R., Xu, M. J., Foster, G. A., Saá, P., Brodsky, J. P., & Stramer, S. L. (2021) · Transfusion Medicine Reviews · doi:10.1016/j.tmrv.2021.07.001 · Cited by 9 · see citing works

The End of Evidence‐Based Everything at the Close of the Global Chapter: Plotting the Next Step on the Spiral

Hall, J. L. (2021) · Public Administration Review · doi:10.1111/puar.13444 · Cited by 8 · see citing works

Serosurvey for SARS-CoV-2 among blood donors in Wuhan, China from September to December 2019

Chang, L., Zhao, L., Xiao, Y., Xu, T., Chen, L., Cai, Y., Dong, X., Wang, C., Xiao, X., Ren, L., et al. (2022) · Protein & Cell · doi:10.1093/procel/pwac013 · Cited by 8 · see citing works

Covid-19: Early Cases and Disease Spread

Reis, J. J., Faou, A. L., Buguet, A., Sandner, G., & Spencer, P. S. (2022) · Annals of Global Health · doi:10.5334/aogh.3776 · Cited by 8 · see citing works

Predicting health crises from early warning signs in patient medical records

Gumustop, S., Gallo‐Bernal, S., McPeake, F., Briggs, D., Gee, M. S., & Pianykh, O. S. (2022) · Scientific Reports · doi:10.1038/s41598-022-23900-8 · Cited by 7 · see citing works

Continuous mutation of SARS-CoV-2 during migration via three routes at the beginning of the pandemic

Konishi, T. (2022) · PeerJ · doi:10.7717/peerj.12681 · Cited by 7 · see citing works

Early Evidence of Circulating SARS-CoV-2 in Unvaccinated and Vaccinated Measles Patients, September 2019–February 2020

Paixao, J., Galangue, M., Gaston, C., Carralero, R., Lino, C., Júlio, G., David, Z., Francisco, M., Sebastião, C. S., Sacomboio, E. N., et al. (2022) · Infection and Drug Resistance · doi:10.2147/idr.s344437 · Cited by 7 · see citing works

Origins of HIV, HCoV-HKU1, SFTSV, and MERS-CoV and Beyond

Liu, W., Liu, P., Liu, W. J., Wang, Q., Tong, Y., & Gao, G. F. (2022) · China CDC Weekly · doi:10.46234/ccdcw2022.171 · Cited by 7 · see citing works

A serological investigation in Southern Italy: was SARS-CoV-2 circulating in late 2019?

Trombetta, C. M., Marchi, S., Viviani, S., Manenti, A., Casa, E., Dapporto, F., Remarque, E. J., Bollati, V., Manini, I., Lazzeri, G., et al. (2022) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2022.2047582 · Cited by 7 · see citing works

Wars and sweets: microbes, medicines and other moderns in and beyond the(ir) antibiotic era

Hutchison, C. D. L. (2022) · Medical Humanities · doi:10.1136/medhum-2021-012366 · Cited by 6 · see citing works

Biorepositories (biobanks) of Human Body Fluids and Materials as Archives for Tracing Early Infections of COVID-19

He, S., & Han, J. (2020) · Environmental Pollution · doi:10.1016/j.envpol.2021.116525 · Cited by 6 · see citing works

Pandemics and cash

Baxamusa, M. H., & Jalal, A. M. (2022) · Journal of Business Finance &amp Accounting · doi:10.1111/jbfa.12657 · Cited by 5 · see citing works

Male-Female Disparities in Years of Potential Life Lost Attributable to COVID-19 in the United States: A State-by-State Analysis

Xu, J. J., Chen, J. T., Belin, T. R., Brookmeyer, R., Suchard, M. A., & Ramirez, C. M. (2021) · Applied Sciences · doi:10.3390/app11167403 · Cited by 5 · see citing works

Using an Administrative and Clinical Database to Determine the Early Spread of COVID-19 at the US Department of Veterans Affairs during the Beginning of the 2019–2020 Flu Season: A Retrospective Longitudinal Study

Lukowsky, L. R., Der‐Martirosian, C., Steers, W. N., Kamble, K. S., & Dobalian, A. (2022) · Viruses · doi:10.3390/v14020200 · Cited by 5 · see citing works

The phase dynamics of the COVID-19 pandemic: a systematic analysis of 213 Countries and Territories

The Nano City Holdings Berhad, N. 1., & Teppone, M. (2022) · Problems of Social Hygiene Public Health and History of Medicine · doi:10.32687/0869-866x-2022-30-3-347-355 · Cited by 4 · see citing works

Detecting Respiratory Viruses Using a Portable NIR Spectrometer—A Preliminary Exploration with a Data Driven Approach

Huang, J.-D., Wang, H., Power, U. F., McLaughlin, J. A., Nugent, C., Rahman, E., Barabas, J., & Maguire, P. D. (2024) · Sensors · doi:10.3390/s24010308 · Cited by 4 · see citing works

Identification of the first COVID-19 infections in the US using a retrospective analysis (REMEDID)

García‐García, D., Morales, E., de la Fuente‐Núñez, C., Vigo, I., Fonfría, E. S., & Bordehore, C. (2022) · Spatial and Spatio-temporal Epidemiology · doi:10.1016/j.sste.2022.100517 · Cited by 4 · see citing works

Evaluating disease outbreaks with syndromic surveillance using medical student clinical rotation patient encounter logs

Bruzda, G., Rawlins, F., Sumpter, C., & Garner, H. R. (2021) · Journal of Osteopathic Medicine · doi:10.1515/jom-2020-0129 · Cited by 4 · see citing works

Descriptive evaluation of antibody responses to severe acute respiratory coronavirus virus 2 (SARS-CoV-2) infection in plasma and gingival crevicular fluid in a nursing home cohort—Arkansas, June–August 2020

Brown, N. E., Lyons, A. K., Schuh, A. J., Stumpf, M. M., Harcourt, J. L., Tamin, A., Rasheed, M. A. U., Mills, L. A., Lester, S. N., Thornburg, N. J., et al. (2021) · Infection Control and Hospital Epidemiology · doi:10.1017/ice.2021.484 · Cited by 4 · see citing works

Performance evaluation of an automatic chemiluminescence immune platform for SARS-CoV-2 neutralizing antibody after vaccination in real world

Li, M., Jiang, R., Wang, E., Xiong, D., Ou, T., Zhang, X., & Dou, X. (2022) · BMC Infectious Diseases · doi:10.1186/s12879-022-07141-8 · Cited by 4 · see citing works

Short-term forecast of U.S. COVID mortality using excess deaths and vector autoregression

Britt, T., Nusbaum, J., Savinkina, A. A., & Shemyakin, A. E. (2023) · Model Assisted Statistics and Applications · doi:10.3233/mas-221392 · Cited by 4 · see citing works

Seroprevalence of SARS-CoV-2 antibodies among healthy blood donors: a systematic review and meta-analysis

Ukwishaka, J., Mela, C. F., Aseneh, J. B., Ettaj, M., Ilboudo, D., Danwang, C., Samadoulougou, S., & Kirakoya‐Samadoulougou, F. (2024) · BMC Public Health · doi:10.1186/s12889-024-20364-5 · Cited by 4 · see citing works

He 'A'ali'i Kū Makani Mai Au: Developing a Cultural Framework for Advancing COVID-19 Related, Community-informed Health Policies.

Kamaka, M. L., Freitas, S. M., Marshall, S. M., Walsh, M. E., Kamakawiwo'ole, S., Miller, J. M., Balaz, K., & Vakalahi, H. F. O. (2021) · Europe PMC (PubMed Central) · Cited by 4 · see citing works

Undetected and Relatively Sustained Severe Acute Respiratory Syndrome Coronavirus 2 Circulation Worldwide During 2019

Petti, S. (2021) · Clinical Infectious Diseases · doi:10.1093/cid/ciab727 · Cited by 4 · see citing works

Evaluation of angiotensin converting enzyme 2 (ACE2), angiotensin II (Ang II), miR-141-3p, and miR-421 levels in SARS-CoV-2 patients: a case-control study

Kakavandi, E., Sadeghi, K., Shayestehpour, M., Mirhendi, H., Foroushani, A. R., Mokhtari‐Azad, T., Shafiei-Jandaghi, N.-Z., & Yavarian, J. (2024) · BMC Infectious Diseases · doi:10.1186/s12879-024-09310-3 · Cited by 3 · see citing works

Practicing COVID-19 Public Health Measures Is Associated With Anxiety and Depression in Undergraduate University Students

Holladay, K. R., Lardier, D. T., Amorim, F. T., Zuhl, M., & Coakley, K. E. (2022) · Frontiers in Public Health · doi:10.3389/fpubh.2022.941730 · Cited by 3 · see citing works

Estimation of renin and D-dimer levels in women with polycystic ovary disease with or without coronavirus infection

Ali, S. I., Khaleel, F. M., & Ali, F. E. (2022) · Baghdad Journal of Biochemistry and Applied Biological Sciences · doi:10.47419/bjbabs.v3i04.151 · Cited by 3 · see citing works

The twin-beginnings of COVID-19 in Asia and Europe – One prevails quicklyPreprint

Wu, C. (2021) · Research Square · doi:10.21203/rs.3.rs-955853/v1 · Cited by 3 · see citing works

Delayed Recognition of Coronavirus Disease 2019 (COVID-19) in New York City: A Descriptive Analysis of COVID-19 Illness Prior to 29 February 2020

Keating, P., Sell, J. L., Chen, J., Ackelsberg, J., Wu, W. Y., Tsoi, B. W., & Weiss, D. (2022) · Clinical Infectious Diseases · doi:10.1093/cid/ciac490 · Cited by 2 · see citing works

Clinical and social determinants of health features of SARS-CoV-2 infection among Black and Caribbean Hispanic patients with heart failure: The SCAN-MP Study

Edmiston, J. B., Cohn, E. G., Teruya, S. L., Sabogal, N., Massillon, D. R., Muralidhar, V., Rodriguez, C., Helmke, S. T., Fine, D. M., Winburn, M. L., et al. (2023) · PLoS ONE · doi:10.1371/journal.pone.0283730 · Cited by 2 · see citing works

Using a Safe System Framework to Examine the Roadway Mortality Increase Pre-COVID-19 and in the COVID-19 Era in New York State

Pressley, J. C., Aziz, Z., Pawlowski, E., Hines, L. M., Roberts, A., Guzman, J., & Bauer, M. (2025) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph22010061 · Cited by 2 · see citing works

Specificity and Confirmation of SARS-CoV-2 Serological Test Methods in Emergency Department Populations across the United States

Daghfal, D., Schneider, R. J., Mohr, P., Frias, E. C., Prostko, J. C., & Sokoll, L. J. (2022) · The Journal of Applied Laboratory Medicine · doi:10.1093/jalm/jfac060 · Cited by 2 · see citing works

Seroprevalence of SARS-CoV-2 antibodies in Seattle, Washington: October 2019–April 2020

McCulloch, D. J., Jackson, M. L., Hughes, J. P., Lester, S. N., Mills, L. A., Freeman, B. D., Rasheed, M. A. U., Thornburg, N. J., & Chu, H. Y. (2021) · PLoS ONE · doi:10.1371/journal.pone.0252235 · Cited by 2 · see citing works

Development and testing of a sampling device for the detection of aerosolized pathogens in indoor environments

Králík, P., Dziedzinská, R., Cap, M., Szabo, Z., Šerý, O., Pavliš, O., & Fiala, P. (2025) · Talanta · doi:10.1016/j.talanta.2025.129145 · Cited by 1 · see citing works

Pandemic Analysis II: Governmental Actions During the Pandemic—Lockdown or No Lockdown?

Seo, S. N. (2022) · Springer eBooks · doi:10.1007/978-3-030-91021-1_4 · Cited by 1 · see citing works

Respiratory illness of unknown cause as an early signal of the COVID-19 pandemic

Chen, R., Kunasekaran, M. P., Moa, A., Lim, S., Chughtai, A. A., Kpozehouen, E. B., Chen, X., Quigley, A. L., & MacIntyre, C. R. (2024) · Global Biosecurity · doi:10.31646/gbio.253 · Cited by 1 · see citing works

Why the Official Theory about COVID-19 Is Not Tenable

Franchi, F. (2025) · International Journal of Vaccine Theory Practice and Research · doi:10.56098/vdwyqd57 · Cited by 1 · see citing works

Steuerung und Freiheit. Eine Antwort auf Frank Nullmeier

Heuling, D. S. (2021) · ZPTh – Zeitschrift für Politische Theorie · doi:10.3224/zpth.v11i2.08 · Cited by 1 · see citing works

COVID-19: Not just another respiratory virus—2020

Tizard, I. R., & Musser, J. M. B. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-98925-1.00010-6 · Cited by 1 · see citing works

Review of Procedures and Challenges Associated with an Epidemiological Surveillance of SARS-CoV-2 in Wastewater

Mainardi, P. H., & Bidóia, E. D. (2022) · Revista Virtual de Química · doi:10.21577/1984-6835.20220051 · Cited by 1 · see citing works

Concordance of SARS-CoV-2 Antibody Results during a Period of Low Prevalence

Miller, C. N., Althoff, K. N., Schlueter, D. J., Anton‐Culver, H., Chen, Q., Garbett, S. P., Ratsimbazafy, F., Thomsen, I. P., Karlson, E. W., Cicek, M. S., et al. (2022) · mSphere · doi:10.1128/msphere.00257-22 · Cited by 1 · see citing works

Lessons learned from the SARS-CoV-2 pandemic; from nucleic acid nanomedicines, to clinical trials, herd immunity, and the vaccination divide

Hussain, H., Ganesh, A., Milane, L. S., & Amiji, M. M. (2023) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2023.2189697 · Cited by 1 · see citing works

Early Identification of SARS-CoV-2 Emergence in the DoD via Retrospective Analysis of 2019-2020 Upper Respiratory Illness SamplesPreprint

Chapleau, R. R., Christian, M., Connors, B., Premo, C., Chao, T. C., Rodriguez, J., Huntsberger, S., Meyer, J., Javorina, A., Reynolds, K., et al. (2021) · medRxiv · doi:10.1101/2021.02.18.21251368 · Cited by 1 · see citing works

Natural Antibodies and Severe Acute Respiratory Syndrome Coronavirus 2–Specific Antibodies in Healthy Asymptomatic Individuals

Steele, E. J., Gorczynski, R. M., Lindley, R. A., & Wickramasinghe, N. C. (2023) · Clinical Infectious Diseases · doi:10.1093/cid/ciad004 · Cited by 1 · see citing works

La incógnita del coronavirus – Parte III

Romero, J. P. (2020) · Revista Peruana de Ginecología y Obstetricia · doi:10.31403/rpgo.v66i2297

Identification of the first COVID-19 infections in the US using a retrospective analysisPreprint

García‐García, D., Morales, E., de la Fuente‐Núñez, C., Vigo, I., Fonfría, E. S., & Bordehore, C. (2021) · Research Square · doi:10.21203/rs.3.rs-707353/v1

Date of introduction and epidemiologic patterns of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in Mogadishu, Somalia: estimates from transmission modelling of satellite-based excess mortality data in 2020

Koltai, M., Warsame, A., Bashiir, F., Freemantle, T. P., Reeve, C., Williams, C., Jit, M., Flasche, S., Davies, N. G. M., CMMID COVID-19 working group, et al. (2021) · Wellcome Open Research · doi:10.12688/wellcomeopenres.17247.1

Comments on COVID-19, a double-edged sword for the environment: a review on the impacts of COVID-19 on the environment

Mohideen, M. M., & Liu, Y. (2022) · Environmental Science and Pollution Research · doi:10.1007/s11356-021-17979-1

Pandemic Analysis I: Global Governance for a Global Pandemic?

Seo, S. N. (2022) · Springer eBooks · doi:10.1007/978-3-030-91021-1_3

Some Yet Unresolved Questions and Mysteries About the COVID-19 Pandemic

Seo, S. N. (2022) · Springer eBooks · doi:10.1007/978-3-030-91021-1_9

Peer Review #2 of "Continuous mutation of SARS-CoV-2 during migration via three routes at the beginning of the pandemic (v0.1)"

(2022) · PeerJ · doi:10.7287/peerj.12681v0.1/reviews/2

Peer Review #1 of "Continuous mutation of SARS-CoV-2 during migration via three routes at the beginning of the pandemic (v0.1)"

(2022) · PeerJ · doi:10.7287/peerj.12681v0.1/reviews/1

Peer Review #2 of "Continuous mutation of SARS-CoV-2 during migration via three routes at the beginning of the pandemic (v0.2)"

(2022) · PeerJ · doi:10.7287/peerj.12681v0.2/reviews/2

NC-COVID: A Time-Varying Compartmental Model for Estimating SARS-CoV-2 Infection Dynamics in North Carolina, USPreprint

Delamater, P. L., & Woodul, R. L. (2022) · medRxiv · doi:10.1101/2022.10.21.22281271

Unspecific reactivity must be excluded in COVID-19 epidemiological analyses or virus tracing based on serologic testing: Analysis of 46,777 post-pandemic samples and 1,114 pre-pandemic samples

Cai, M.-J., Lin, J., Zhu, J.-H., Dai, Z., Lin, Y., & Liang, X. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.1018578

Narratív bűnbakképzés a pandémia alatt : Kit/mit és miért okolunk a koronavírusért?

Bobák, S. (2021) · Tabula · doi:10.54742/tabula.2021.2.02

Reply to Steele et al

Althoff, K. N., Gebo, K. A., & Schully, S. D. (2023) · Clinical Infectious Diseases · doi:10.1093/cid/ciad005

Borders, Boundaries, and Identities: Navigating the Barriers to Solidarity and Cohesion in a Pandemic

Oyekan, A. O., & Balogun, W. A. (2023) · Springer eBooks · doi:10.1007/978-3-031-17429-2_10

Framework for Regulatory Regulation of Blood and Blood Products in India, United States and Europe

Shyamala, S., Sonia, K., & Manikandan, K. (2023) · Indian Journal of Pharmaceutical Sciences · doi:10.36468/pharmaceutical-sciences.1210

Electrogeneration and characterization of poly(2-aminobenzamide) with application in the development of an electrochemical genosensor for the detection of severe acute respiratory syndrome coronavirus 2 genome

do Nascimento, L. A., de Oliveira, D. B., Martins, H. R., Lima, T. M., Soares, P. I., Pereira, A. C., Franco, D. L., Ottone, V. D. O., Silva, T. J., Rocha‐Vieira, E., et al. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-95105-0.00003-6

Retrospective Search for SARS-CoV-2 during the Winter Season, 2019-2020 in Social Security Population of Mexico

Yaah, J. E. A., Cabrera-Gaytán, D. A., Tinoco, C. E. S., Grajales-Muñíz, C., Vallejos-Parás, A., Hernández, Y. M. A., Miguel, B. M., Bautista, P. F. H., & Muño, J. E. (2024) · Journal of Community Medicine & Public Health · doi:10.29011/2577-2228.100418

Serologic Testing of US Blood Donations to Identify Severe Acute Respiratory Syndrome Coronavirus 2 and Other Coronaviruses, December 2019 to July 2020

Grimm, K. E., Saá, P., Cheedarla, N., Gerty, M. S., Groves, J. A., Dodd, R. Y., Roback, J. D., & Stramer, S. L. (2024) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofae351

SARS-CoV-2 seroprevalence in people living with HIV in South Sudan

Chun, H., Lodiongo, D. K., Milligan, K., Lesuk, G. J., Patel, D., Shiraishi, R. W., Martin, D. L., Simon, A. K., Dirlikov, E., Patel, H., et al. (2024) · IJID Regions · doi:10.1016/j.ijregi.2024.100421

Severe acute respiratory syndrome coronavirus 2-reactive salivary antibody detection in South Carolina emergency healthcare workers, September 2019–March 2020

Meltzer, H. C., Goodwin, J. L., Fowler, L. A., Britt, T. W., Pirrallo, R. G., & Grier, J. T. (2024) · Epidemiology and Infection · doi:10.1017/s0950268824000967

Serologic Testing of US Blood Donations to Identify Severe Acute Respiratory Syndrome Coronavirus 2 and Other Coronaviruses, December 2019 to July 2020

Grimm, K. E., Saá, P., Cheedarla, N., Gerty, M. S., Groves, J. A., Dodd, R. Y., Roback, J. D., & Stramer, S. L. (2024) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofae351

Serosurvey for SARS-CoV-2 among blood donors in Wuhan, China from September to December 2019

Chang, L., Zhao, L., Xiao, Y., Xu, T., Chen, L., Cai, Y., Dong, X., Wang, C., Xiao, X., Ren, L., et al. (2022) · Protein & Cell · doi:10.1093/procel/pwac013 · Cited by 8 · see citing works

Characteristics of US Blood Donors Testing Reactive for Antibodies to SARS-CoV-2 Prior to the Availability of Authorized Vaccines

Dodd, R. Y., Spencer, B. R., Xu, M. J., Foster, G. A., Saá, P., Brodsky, J. P., & Stramer, S. L. (2021) · Transfusion Medicine Reviews · doi:10.1016/j.tmrv.2021.07.001 · Cited by 9 · see citing works

Patterns of Antibody Response to Severe Acute Respiratory Syndrome Coronavirus 2 Among 1.6 Million Blood Donors: Impact of Vaccination, United States, December 2020–June 2021

Dodd, R. Y., Notari, E. P., Brodsky, J. P., Foster, G. A., Xu, M. J., Saá, P., & Stramer, S. L. (2021) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiab514 · Cited by 16 · see citing works

Undetected and Relatively Sustained Severe Acute Respiratory Syndrome Coronavirus 2 Circulation Worldwide During 2019

Petti, S. (2021) · Clinical Infectious Diseases · doi:10.1093/cid/ciab727 · Cited by 4 · see citing works